Yutaka Shimazu, Junya Kanda, Kazuhito Suzuki, Akinori Wada, Taku Kikuchi, Takashi Ikeda, Nobuhiro Tsukada, Akiyoshi Miwa, Mitsuhiro Itagaki, Shinichi Kako, et al. The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation. Cancer science. 2024
Hiromi Hayashi, Makoto Iwasaki, Hideki Nakasone, Reo Tanoshima, Masashi Shimabukuro, Wataru Takeda, Tetsuya Nishida, Shinichi Kako, Shin-Ichiro Fujiwara, Yuta Katayama, et al. Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Cytotherapy. 2023
Chihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, Shuka Furuki, Atsuto Noguchi, Shunsuke Koyama, Takashi Oyama, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, et al. Cost-effectiveness of anti-BCMA chimeric antigen receptor T cell therapy in relapsed/ refractory multiple myeloma. Transplantation and cellular therapy. 2023
Takashi Nagayama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, et al. Early reversal of the lymphocyte-to-monocyte ratio after allogeneic-hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis. Clinical transplantation. 2023. e15116